北京怡和嘉业医疗科技股份有限公司（“怡和嘉业”）于11月1日在深圳证券交易所创业板成功上市，募集资金19.18亿元。海问律师事务所在项目中担任发行人律师，竞天公诚律师事务所则为保荐机构与承销商提供服务。

怡和嘉业于2001年设立于北京，是一家国家级专精特新“小巨人”企业，为国内家用无创呼吸机及通气面罩龙头企业。按 2020 年中国家用无创呼吸机及通气面罩出口销售额计，怡和嘉业市场份额均排名第一。

海问本项目的负责合伙人为高巍律师、肖毅律师、张汉国律师。

Haiwen, JTGC on China ventilator manufacturer’s $262 mln IPO

Haiwen & Partners has advised BMC Medical Co., Ltd. (BMC), a Chinese ventilator manufacturer, on its $262 million initial public offering on Shenzhen’s ChiNext, while Jingtian & Gongcheng acted for the sponsors in the deal.

Established in Beijing in 2001, BMC was built to overcome the discomfort of chronic respiratory disease with products and services. It develops and markets non-invasive ventilators, high-flow nasal cannula oxygenation, breathing tubes, and other products. BMC markets its products primarily throughout China, and it also sells in more than 100 countries and regions around the world.

The Haiwen team was led by partners Gao Wei, Xiao Yi, and Zhang Hanguo.